NIH-funded research NIH-funded research

Investigating RNA modifications in the nervous system

Official title: Epitranscriptomic regulation in the mammalian nervous system

Funded at University of Pennsylvania · NIH-10893664 · Data updated 2026-11-12

This study is looking at how changes in RNA can influence the growth and function of the brain, which could help us understand and improve treatments for brain disorders that affect people.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startDecember 23, 2024
Project endNovember 30, 2032
Funding year2025
Award (this year)$985,026
NIH project number1R35NS137480-01
Project IDNIH-10893664 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals with developmental, neurological, psychiatric, or degenerative brain disorders.

Less likely to help

Patients with conditions unrelated to RNA modifications or those outside the age range of 21+ years may not receive benefit from this research.

What this research studies

This research explores how various RNA modifications affect the development and function of the mammalian nervous system. By utilizing advanced techniques such as human induced pluripotent stem cell-derived brain organoids, the study aims to uncover the roles of these modifications in brain disorders. The research will involve both mouse models and human brain organoids to better understand the implications of epitranscriptomic regulation. Patients may benefit from insights gained into the mechanisms underlying neurological and psychiatric conditions.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating brain disorders linked to RNA modification dysregulation.

How similar studies have gone: Other research has shown promising results in understanding RNA modifications, particularly in the context of mRNA vaccines, indicating potential for success in this area.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Ming, Guo-Li — University of Pennsylvania
  • Study coordinator: Ming, Guo-Li

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.